Welcome to our dedicated page for HEALTHY EXTRACTS news (Ticker: HYEX), a resource for investors and traders seeking the latest updates and insights on HEALTHY EXTRACTS stock.
Healthy Extracts Inc. reports developments in science-based nutraceutical supplements, oral delivery technology, and precision-dose gummy manufacturing. The company develops, manufactures, and markets proprietary supplements for brain, heart, and gut health, with product formats that include gel packs, functional drinking straws, and gummies through its Gummy USA subsidiary.
Recurring company news includes revenue updates, direct-to-consumer and retail sales activity, Amazon subscription trends, product launches such as STAT10 and 4Sleep, and B2B manufacturing relationships for private-label and branded gummy products. Coverage also reflects the completed Gummy USA combination, which added a HACCP, GMP-certified and FDA-registered manufacturing facility to the company’s nutraceutical platform.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Healthy Extracts Inc. (OTCQB: HYEX) reported a record net revenue of $2.3 million for 2022, marking a 34% increase over the previous year, driven by product expansion and new distribution channels. Gross profit rose to $1.4 million with a gross margin of 60.9%. Operating expenses decreased 12% to $2.3 million, leading to a net loss of $983,000, down 51% year-over-year. Subscriber base grew 87% year-over-year, enhancing future revenue visibility. The company also launched several products and entered traditional retail with Natural Grocers, aligning with increasing consumer demand for plant-based health solutions.
Summary not available.